RT Journal Article
SR Electronic
T1 Is the basic reproduction number for the covid-19 epidemic estimated by the SIR model reliable?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.11.20210831
DO 10.1101/2020.10.11.20210831
A1 Yang, Hyun Mo
A1 Lombardi Junior, Luis Pedro
A1 Yang, Ariana Campos
YR 2020
UL http://medrxiv.org/content/early/2020/10/20/2020.10.11.20210831.abstract
AB The transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becomes pandemic but presents different patterns in the world. To describe the epidemic of coronavirus disease 2019 (covid-19) in each country or region, mathematical models were formulated aiming the estimation of the basic reproduction number R0. The simplest mathematical model, the SIR model, provided a lower estimation for R0, ranging from 1.5 to 3.0. However, more elaborate models, taking into account the natural history of covid-19, must be used to obtain a more reliable estimation of R0. One of the elaborated models presented here estimated a higher value for R0, that is, 6.54 and 5.88 for, respectively, São Paulo State (Brazil) and Spain. It is worth stressing that this model assumed that severe covid-19 cases were not participating in the SARS-CoV-2 transmission chain, which can not be assumed in the SIR model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData obtained from ministery of health fo Spain and São Paulo State. https://www.seade.gov.br/coronavirus/ https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/home.htm